GMAs Digital
EXIT
RIP
Year Invested:
2021
Sector:
Pharmaceuticals, Medical Devices, Biotechnology
Key people:
Zlatko Boni, Mark Connolly

The healthcare industry is one of the world's largest and fastest-growing industries. All health technologies including drugs and medical devices are a result of a lengthy and expensive process of scientific discovery, clinical testing and finally commercialization. In an increasingly competitive landscape, pharma companies need powerful solutions that make the commercialization process more efficient and increase the likelihood of success.

GMAS Digital is developing a platform that enables mapping and optimization of activities ensuring higher productivity and alignment of cross-functional teams. The company utilizes extensive consulting experience leveraged by computer vision and proprietary software to store and map information for easy use by internal stakeholders throughout the product life cycle. Company is co-founded by a Swiss consultancy with 10 years of experience in medical commercialization and an expert in digital trends supported by a team of developers. With big corporate structures and complex regulatory environments, pharma and medical device companies need to outsource and automate processes. The platform ensures that this is done faster, better and cheaper resulting in greater productivity. Our company is bringing partners and clients to the platform making it a one stop shop for tech- enabled services in the pharmaceutical and medical device industry.

We love bold founders and we provide ‘’Capital for the Bold’’. Get it?

Submit
Yes I am